From the Deputy Commissioner of the Food and Drug Administration: "I present to you the Food and Drug Administration's (FDA) Annual Financial Report for fiscal year (FY) 2002. I am pleased to report that FDA has earned its fifth consecutive 'clean' opinion on its audited financial statements. By comparing the fiscal information from these statements with the summary performance information reported under the Government Performance and Results Act, FDA is able to demonstrate how this investment yields valuable results. After the events of September 11, 2001, protecting our homeland has become more important than ever before. As the nation's foremost consumer safety organization, FDA strives to assure a safe food supply through critical science-based prevention strategies; ensures medical product safety and their use by millions of Americans; brings safe and effective new technologies to a world-wide market; and monitors emerging hazards through surveillance systems and monitors about eight million import shipments that enter the United States. Additional FY 2002 resources allowed FDA to facilitate the availability of new bioterrorism tools accelerating the availability of medical products necessary for public health preparedness and to strengthen its surveillance, investigational, and laboratory support for detection and management of product contamination for foods, medical products, and blood."
Government Printing Office: http://permanent.access.gpo.gov/